FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Aarti Drugs Buyback 2024 and Jai Corp Buyback 2024.
Aarti Drugs Buyback 2024 is a Tender Offer buyback proposed to list at BSE, NSE while Jai Corp Buyback 2024 is a Tender Offer proposed to list at BSE, NSE.
Aarti Drugs Ltd. | Jai Corp Ltd. | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Logo | ||||||||||||||||||||
Type of Buyback | Tender Offer | Tender Offer | ||||||||||||||||||
Listing At | BSE, NSE | BSE, NSE | ||||||||||||||||||
Face Value | ₹10 per share | ₹1 per share | ||||||||||||||||||
Buyback Price | ₹900 per share | ₹400 per share | ||||||||||||||||||
Issue Size | 6,65,000 shares | 29,44,415 shares | ||||||||||||||||||
Issue Size (Amount) | ₹59.85 Crores | ₹117.78 Crores | ||||||||||||||||||
Buyback Ratio |
|
|
||||||||||||||||||
Registrar | Link Intime India Private Ltd | Kfin Technologies Limited | ||||||||||||||||||
Lead Managers | Inga Ventures Pvt Ltd | Navigant Corporate Advisors Ltd | ||||||||||||||||||
Necessity of the buyback | The Company is proposing the Buyback to service the equity more efficiently. Additionally, the Company’s management strives to increase equity shareholder's value and the Buyback would result in amongst other things:
|
The Buy-Back is being undertaken, inter-alia, for the following reasons:
|
Aarti Drugs Buyback 2024 and Jai Corp Buyback 2024 buyback timetable. The investors should have the company's shares in their demat accounts as of the record date. Aarti Drugs Buyback 2024 Buyback record date is Sep 05, 2024. Jai Corp Buyback 2024 Buyback record date is Sep 10, 2024.
Aarti Drugs Ltd. | Jai Corp Ltd. | |
---|---|---|
Record Date | Sep 05, 2024 | Sep 10, 2024 |
Offer Open Date | Sep 11, 2024 | Sep 13, 2024 |
Offer Closure Date | Sep 19, 2024 | Sep 20, 2024 |
Last date for receipt of tender forms | Sep 19, 2024 | Sep 20, 2024 |
Finalisation of buyback | Sep 25, 2024 | Sep 26, 2024 |
Last Date for settlment of bids | Sep 26, 2024 | Sep 27, 2024 |
Last Date for extinguishment of shares | Oct 08, 2024 | Oct 01, 2024 |
Comparison of Aarti Drugs Buyback 2024 and Jai Corp Buyback 2024 financial data. The table below also includes a list of all relevant information like Stock Market Data, Compay Information, Lead Manager and Registrar.
Aarti Drugs Ltd. | Jai Corp Ltd. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial | Aarti Drugs Ltd. Financial Information (Restated Consolidated)Aarti Drugs Ltd.'s revenue decreased by -7% and profit after tax (PAT) rose by 3% between the financial year ending with March 31, 2024 and March 31, 2023.
|
Jai Corp Ltd. Financial Information (Restated Consolidated)Jai Corp Ltd.'s revenue decreased by -19% and profit after tax (PAT) rose by 488% between the financial year ending with March 31, 2024 and March 31, 2023.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock price at BSE | Stock price at BSE (in preceding 3 months)
|
Stock price at BSE (in preceding 3 months)
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock price at NSE | Stock price at NSE (in preceding 3 months)
|
Stock price at NSE (in preceding 3 months)
|
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|